Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN99916292Phase 3Completed
Phase 3, randomised trial in coronavirus disease 2019 (COVID-19) comparing MMR vaccine with Placebo (2 arms). Primary endpoint: Symptomatic COVID-19 by day 60. Started Oct 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN99916292.